Skip to main content

Excited Delirium Syndrome: Diagnosis and Treatment

  • Chapter
  • First Online:
Behavioral Emergencies for Healthcare Providers

Abstract

Excited delirium syndrome (ExDS) is a specific type of agitation in which individuals typically present in an extremely violent and uncontrollable manner. The actual existence of ExDS, which is not currently listed in the APA Diagnostic and Statistical Manual (DSM), has been criticized by some as having been “invented” to classify and ultimately justify deaths that occur in highly agitated individuals during police arrest and restraint. Many researchers, however, believe that ExDS has a long history and has been described using various terms over the past two centuries. Although ExDS does not always result in death, it does carry relatively high mortality compared to other acute behavioral emergencies. Similar to delirium generally, ExDS is a behavioral manifestation of a medical emergency. Knowledge of this condition is therefore significant for individuals who take care of patients in the acute setting, both in and out of the hospital. This includes law enforcement officers, emergency medical system (EMS) providers, critical care psychiatrists, and emergency physicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ACEP Excited Delirium Task Force. White Paper Report on Excited Delirium Syndrome; 2009. Available at https://www.acep.org/uploadedFiles/ACEP/Practice_Resources/disater_and_EMS/EMS_resources/ACEP%20Excited%20Delirium%20White%20Paper%20final%20form.pdf. Accessed on 1 Oct 2017.

  2. Hall C, Butler C, Kader A, et al. Police use of force, injuries and death: prospective evaluation of outcomes for all police use of force/restraint including conducted energy weapons in a large Canadian city. Acad Emerg Med. 2009;16(4):S198–9.

    Google Scholar 

  3. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med. 2001;19:187–91.

    Article  CAS  PubMed  Google Scholar 

  4. Bell L. On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinarily observed or described combination of symptoms, as to render it probable that it may be an overlooked and hitherto unrecorded malady. Am J Insanity. 1849;6:97–127.

    Google Scholar 

  5. Kraines SH. Bell’s mania. Am J Psychiatry. 1934;91:29–40.

    Article  Google Scholar 

  6. Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci. 1985;30(3):873–80.

    Article  CAS  PubMed  Google Scholar 

  7. Reay DT, Fligner CL, Stilwell AD, et al. Positional asphyxia during law enforcement transport. Am J Forensic Med Pathol. 1992;13(2):90–7.

    Article  CAS  PubMed  Google Scholar 

  8. O’Halloran RL, Lewman LV. Restraint asphyxiation in excited delirium. Am J Forensic Med Pathol. 1993;14(4):289–95.

    Article  PubMed  Google Scholar 

  9. Zipes DP. Sudden cardiac arrest and death following application of shocks from a TASER electronic control device. Circulation. 2012;125(20):2417–22. Epub e2012 Apr 30. Erratum in: Circulation. 2013;127(23):e839. Circulation. 2012;126(2):e27.

    Article  PubMed  Google Scholar 

  10. Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC. National Association of Medical Examiners position paper on the certification of cocaine-related deaths. Am J Forens Med Sci. 2004;25(1):11–3.

    Google Scholar 

  11. DiMaio TG, DiMaio VJM. Excited delirium syndrome cause of death and prevention. 1st ed. Boca Raton, FL: Taylor & Francis Group; 2006. p. 1–60.

    Google Scholar 

  12. Grant JR, Southall PE, Mealey J, Scott SR, Fowler DR. Excited delirium deaths in custody past and present. Am J Forensic Med Pathol. 2009;30:1–5.

    Article  PubMed  Google Scholar 

  13. Otahbuchi M, Cevik C, Bagdure S, Nugent K. Excited delirium, restraints, and unexpected death: a review of pathogenesis. Am J Forensic Med Pathol. 2010;31(2):1–6.

    Google Scholar 

  14. Takeuchi A, Ahern TL, Henderson SO. Excited delirium. West J Emerg Med. 2011;XII(1):77–83.

    Google Scholar 

  15. Vilke GM, DeBard ML, Chan TC, et al. Excited Delirium Syndrome (ExDS): defining based on a review of the literature. J Emerg Med. 2012;43(5):897–905.

    Article  PubMed  Google Scholar 

  16. Gerold KB, Gibbons ME, Fisette RE Jr, et al. Review, clinical update, and practice guidelines for excited delirium syndrome. J Spec Oper Med. 2015;15(1):62–9.

    Article  PubMed  Google Scholar 

  17. Gill JR. The syndrome of excited delirium. Forensic Sci Med Pathol. 2014;10(2):223–8.

    Article  PubMed  Google Scholar 

  18. Vilke GM, Payne-James J, Karsch SB. Excited Delirium Syndrome (ExDS): redefining an old diagnosis. J Forens Legal Med. 2012;19:7–11.

    Article  Google Scholar 

  19. Vilke GM, Bozeman WP, Dawes DM, et al. Excited delirium syndrome (ExDS): treatment options and considerations. J Forensic Legal Med. 2012;19(3):117–21.

    Article  Google Scholar 

  20. Vilke GM, Wilson MP. Agitation: what every emergency physician should know. EM Rep. 2009;30(19):1–8.

    Google Scholar 

  21. Penders TM. The syndrome of excited delirium following use of “bath salts”. J Clin Psychiatry. 2013;74(5):518.

    Article  PubMed  Google Scholar 

  22. Escobedo LG, Ruttenber AJ, Agocs MM, Anda RF, Wetli CV. Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida. Arch Pathol Lab Med. 1991;115(9):900–5.

    CAS  PubMed  Google Scholar 

  23. Ruttenber AJ, Sweeney PA, Mendlein JM, Wetli CV. Preliminary findings of an epidemiologic study of cocaine-related deaths, Dade County, Florida, 1978–85. NIDA Res Monogr. 1991;110:95–112.

    CAS  PubMed  Google Scholar 

  24. Mirchandani HG, Rorke LB, Sekula-Perlman A, Hood IC. Cocaine-induced agitated delirium, forceful struggle, and minor head injury: a further definition of sudden death during restraint. Am J Forensic Med Pathol. 1994;15(2):95–9.

    Article  CAS  PubMed  Google Scholar 

  25. Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med. 1996;14:425–8.

    Article  CAS  PubMed  Google Scholar 

  26. Hick JL, Smith SW, Lynch MT. Metabolic acidosis in restraint-associated cardiac arrest: a case series. Acad Emerg Med. 1999;6(3):239–43.

    Article  CAS  PubMed  Google Scholar 

  27. Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol. 1999;20(2):120–7.

    Article  CAS  PubMed  Google Scholar 

  28. Allam S, Noble JS. Cocaine-excited delirium and severe acidosis. Anesthesia. 2001;56(4):385–6.

    Article  CAS  Google Scholar 

  29. Gruszecki AC, McGwin G, Robinson A, Davis GG. Unexplained sudden death and the likelihood of drug abuse. J Forensic Sci. 2005;50(2):1–4.

    Article  Google Scholar 

  30. Bunai Y, Akaza K, Jiang WX, Nagai A. Fatal hyperthermia associated with excited delirium during an arrest. Leg Med (Tokyo). 2008;10(6):306–9.

    Article  Google Scholar 

  31. Maher PJ, Walsh M, Burns T, Strote J. Prehospital resuscitation of a man with excited delirium and cardiopulmonary arrest. CJEM. 2014;16(1):80–3.

    Article  PubMed  Google Scholar 

  32. Plush T, Shakespeare W, Jacobs D, Ladi L, Sethi S, Gasperino J. Cocaine-induced agitated delirium: a case report and review. J Intensive Care Med. 2015;30(1):49–57.

    Article  PubMed  Google Scholar 

  33. Kodikara S, Cunningham K, Pollanen MS. “Excited delirium syndrome”: is it a cause of death? Leg Med (Tokyo). 2012;14(5):252–4.

    Article  Google Scholar 

  34. Mash DC, Duque L, Pablo J, et al. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Sci Int. 2009;190(1–3):e13–9.

    Article  CAS  PubMed  Google Scholar 

  35. Mash DC. Biochemical brain markers in excited delirium deaths. In: Kroll MW, Ho JD, editors. TASER conducted electrical weapons: physiology, pathology, and law. New York, NY: Springer; 2009. p. 365–77.

    Chapter  Google Scholar 

  36. Johnson MM, David JA, Michelhaugh SK, et al. Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium. J Forensic Sci. 2012;57(6):1519–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Schiavone S, Riezzo I, Turillazzi E, et al. Involvement of the NADPH oxidase NOX2-derived brain oxidative stress in an unusual fatal case of cocaine-related neurotoxicity associated with excited delirium syndrome. J Clin Psychopharmacol. 2016;36(5):513–7.

    Article  CAS  PubMed  Google Scholar 

  38. Schiavone S, Neri M, Mhillaj E, et al. The role of the NADPH oxidase derived brain oxidative stress in the cocaine-related death associated with excited delirium: a literature review. Toxicol Lett. 2016;258:29–35.

    Article  CAS  PubMed  Google Scholar 

  39. Richmond JS, Berlin JS, Fishkind A, et al. Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med. 2012;13(1):17–25.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wilson MP, Zeller SL. Reconsidering psychiatry in the emergency department. J Emerg Med. 2012;43(5):771–2.

    Article  PubMed  Google Scholar 

  41. Ho JD, Dawes DM, Nelson RS, et al. Acidosis and catecholamine evaluation following simulated law enforcement “Use of force” Encounters. Acad Emerg Med. 2010;12:E60–E6.

    Article  Google Scholar 

  42. Ho JD, Dawes DM, Cole JB, et al. Lactate and pH evaluation in exhausted humans with prolonged TASER® X26 exposure or continued exertion. Forensic Sci Int. 2009;190:80–6.

    Article  CAS  PubMed  Google Scholar 

  43. Ho JD, Dawes DM, Bultman LL, et al. Prolonged TASER® use on exhausted humans does not worsen markers of acidosis. Am J Emerg Med. 2009;27:413–8.

    Article  PubMed  Google Scholar 

  44. Nordstrom K, Zun LS, Wilson MP, et al. Medical evaluation and triage of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. West J Emerg Med. 2012;13(1):3–10.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Wilson MP, Pepper D, Currier GW, Holloman GH, Feifel D. The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 2012;13(1):26–34.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Richards JR, Schneir AB. Droperidol in the emergency department: is it safe? J Emerg Med. 2001;24(4):441–7.

    Article  Google Scholar 

  47. Zeller SL, Rhoades R. Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther. 2010;32:403–25.

    Article  CAS  PubMed  Google Scholar 

  48. Citrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry. 2007;68:1876–85.

    Article  CAS  PubMed  Google Scholar 

  49. Wilson MP, MacDonald K, Vilke GM, Ronquillo L, Feifel D. Use of intramuscular ziprasidone by ED clinicians and its effect on vital signs. National Behavioral Emergencies Conference, December 1–2, 2011; Las Vegas, Nevada.

    Google Scholar 

  50. Wilson MP, MacDonald KS, Vilke GM, Feifel D. A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. J Emerg Med. 2012;43(5):790–7.

    Article  PubMed  Google Scholar 

  51. Wilson MP, MacDonald KS, Vilke GM, Feifel D. Potential complications of combining intramuscular olanzapine with benzodiazepines in agitated emergency department patients. J Emerg Med. 2012;43(5):889–96.

    Article  PubMed  Google Scholar 

  52. Macdonald K, Wilson MP, Minassian A, et al. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients. Gen Hosp Psychiatry. 2010;32(4):443–5.

    Article  PubMed  Google Scholar 

  53. Green SM, Roback MG, Kennedy RM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–61.

    Article  PubMed  Google Scholar 

  54. Burnett AM, Watters BJ, Barringer KW, et al. Laryngospasm and hypoxia after intramuscular administration of ketamine to a patient in excited delirium. Prehosp Emerg Care. 2012;16(3):412–4.

    Article  PubMed  Google Scholar 

  55. Roberts JR, Geeting GK. Intramuscular ketamine for the rapid tranquilization of the uncontrollable, violent, and dangerous adult patient. J Trauma. 2001;51:1008–10.

    Article  CAS  PubMed  Google Scholar 

  56. Hick JL, Ho JD. Ketamine chemical restraint to facilitate rescue of a combative “jumper”. Prehosp Emerg Care. 2005;9(1):85–9.

    Article  PubMed  Google Scholar 

  57. Cole JB, Klein LR, Nystrom PC, et al. A prospective study of ketamine as primary therapy for prehospital profound agitation. Am J Emerg Med. 2017;36(5):789–96.

    Article  PubMed  Google Scholar 

  58. Scaggs TR, Glass DM, Hutchcraft MG, et al. Prehospital ketamine is a safe and effective treatment for excited delirium in a community hospital based EMS system. Prehosp Disaster Med. 2016;31(5):563–9.

    Article  PubMed  Google Scholar 

  59. Scheppke KA, Braghiroli J, Shalaby M, et al. Prehospital use of i.m. ketamine for sedation of violent and agitated patients. West J Emerg Med. 2014;15(7):736–41.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Hopper AB, Vilke GM, Castillo EM, Campillo A, Davie T, Wilson MP. Ketamine use for acute agitation in the emergency department. J Emerg Med. 2015;48(6):712–9.

    Article  PubMed  Google Scholar 

  61. Battaglia J, Moss S, Rush J, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 1997;15(4):335–40.

    Article  CAS  PubMed  Google Scholar 

  62. Powney MJ, Adams CE, Jones H. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2012;11(11):CD009377.

    PubMed  Google Scholar 

  63. Ostinelli EG, Brooke-Powney MJ, Li X, Adams CE. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2017;7:CD009377.

    PubMed  Google Scholar 

  64. Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371(24):2309–19.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael P. Wilson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wilson, M.P., Vilke, G.M. (2021). Excited Delirium Syndrome: Diagnosis and Treatment. In: Zun, L.S., Nordstrom, K., Wilson, M.P. (eds) Behavioral Emergencies for Healthcare Providers. Springer, Cham. https://doi.org/10.1007/978-3-030-52520-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52520-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52519-4

  • Online ISBN: 978-3-030-52520-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics